Author Question: Natural disasters present the largest risk for infrastructure loss. Indicate whether the ... (Read 77 times)

lbcchick

  • Hero Member
  • *****
  • Posts: 550
Natural disasters present the largest risk for infrastructure loss.
 
  Indicate whether the statement is true or false

Question 2

Which of the following was one of the factors that opened the path for development of the client-server architecture?
 
  A) use of mainframes as the basis of ICT architecture
  B) development of PC operating systems
  C) evolution of virtualization software
  D) introduction of cloud computing


asware1

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

TRUE

Answer to Question 2

B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

There are actually 60 minerals, 16 vitamins, 12 essential amino acids, and three essential fatty acids that your body needs every day.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library